S. O. Chretien
S. O. Chretien has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Vitaliy Viktorovich Pavlov
Novosibirsk Research Institute of Traumatology and Orthopedics n.a. Ya.L. Tsivyan, Novosibirsk, Russia
4 shared publications - Taalaibek U. Sheraliev
Tsivyan Novosibirsk Res Inst Traumatol & Orthopae, Novosibirsk, Russia
3 shared publications - Aleksandr Gennadyevich Samokhin
Novosibirsk Research Institute of Traumatology and Orthopaedics n.a. Ya.L. Tsivyan
2 shared publications - Andrey Aleksandrovich Korytkin
Y.L. Tsivyan Novosibirsk Scientific Research Institute of Traumatology and Orthopedics
2 shared publications - Nina V. Tikunova
Laboratory of Molecular Microbiology, Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Sciences, Novosibirsk 630090, Russia
2 shared publications - Andrey Kechin
Institute of Chemical Biology and Fundamental Medicine, Novosibirsk 630090, Russia
1 shared publication
Latest Publications
- Open Access
- 24 October 2026
- Published by Russian Ilizarov Scientific Centre Restorative Traumatology and Orthopaedics in Genij Ortopedii
- Vol. 32 (5) , 593-606
Adjuvant phage therapy in periprosthetic joint infection: comparative analysis of medium-term treatment results
Introduction Periprosthetic joint infection (PJI) is one of the major complications following primary and revision total hip arthroplasty, accounting for 15–25 % of revision procedures. PJI caused by multidrug-resistant microorganisms is associated with a higher risk of recurrence and severe consequences, including loss of limb function and amputation. The growing prevalence of antimicrobial resistance, particularly among staphylococci and Gram-negative bacteria, further complicates the PJI treatment. Purpose To conduct a comparative analysis of the mid-term results of adjuvant phage therapy in combination with standard therapy in patients with periprosthetic hip joint infection caused by multidrug-resistant microorganisms. Materials and Methods The study was designed as a non-randomized, open-label, prospective study that included 39 patients with chronic periprosthetic hip joint infection (hip PJI). All patients underwent appropriate surgical treatment and were divided into two groups: the study group ( n = 19), in which personalized phage therapy was used in combination with targeted antibiotic therapy, and the comparison group ( n = 20), which received antibiotic therapy alone. The median follow-up period was at least 120 weeks; the recurrence rate was assessed after 104 weeks. The primary criterion for treatment efficacy was eradication of PJI and the absence of PJI recurrence within 104 weeks after revision arthroplasty. Results The odds of PJI recurrence within 104 weeks of follow-up in the study group were five times lower than in the comparison group ( OR = 0.2), with recurrence rates of 10.5 % and 45.0 %, respectively ( p = 0.031). The study group demonstrated significantly higher implant survival compared with the comparison group: implant survival at 104 weeks reached 89 % and 55 %, respectively. The mean risk ratio for implant loss in the David Cox proportional hazards model was 0.17 (log-rank test, p = 0.012). The study group also showed a significantly higher proportion of recovered patients compared with the comparison group, with rates of 89.5 % and 55.0 %, respectively ( OR = 6.3; p = 0.031). Discussion The results obtained for the causative PJI agents are consistent with the data in the literature. Both groups were dominated by cefoxime-resistant forms of staphylococci as a marker antibiotic, which reflects the PJI patterns of development in arthroplasty. The use of antibacterial drugs in large doses for eradication of pathogenic bacteria in biofilms leads to the accumulation of mutations in the genomes of the causative PJI agents, which is the reason for the development of drug resistance and recurrence of infection. The use of alternative therapies for PJI, in particular phage therapy, may change the treatment strategy. Adjuvant phage therapy has potential in the PJI caused by antibiotic-resistant pathogens. Conclusion Adjuvant phage therapy combined with antibiotic therapy is an effective treatment modality for periprosthetic hip joint infection caused by multidrug-resistant pathogens and may significantly reduce the recurrence rate of periprosthetic infection and thereby improve clinical outcomes. Further large randomized studies are required to confirm our findings and to use this method.
- 24 October 2026
- Published by Russian Ilizarov Scientific Centre Restorative Traumatology and Orthopaedics in Genij Ortopedii
- Vol. 32 (5) , 593-606
Open AccessAdjuvant phage therapy in periprosthetic joint infection: comparative analysis of medium-term treatment results
Introduction Periprosthetic joint infection (PJI) is one of the major complications following primary and revision total hip arthroplasty, accounting for 15–25 % of revision procedures. PJI caused by multidrug-resistant microorganisms is associated with a higher risk of recurrence and severe consequences, including loss of limb function and amputation. The growing prevalence of antimicrobial resistance, particularly among staphylococci and Gram-negative bacteria, further complicates the PJI treatment. Purpose To conduct a comparative analysis of the mid-term results of adjuvant phage therapy in combination with standard therapy in patients with periprosthetic hip joint infection caused by multidrug-resistant microorganisms. Materials and Methods The study was designed as a non-randomized, open-label, prospective study that included 39 patients with chronic periprosthetic hip joint infection (hip PJI). All patients underwent appropriate surgical treatment and were divided into two groups: the study group ( n = 19), in which personalized phage therapy was used in combination with targeted antibiotic therapy, and the comparison group ( n = 20), which received antibiotic therapy alone. The median follow-up period was at least 120 weeks; the recurrence rate was assessed after 104 weeks. The primary criterion for treatment efficacy was eradication of PJI and the absence of PJI recurrence within 104 weeks after revision arthroplasty. Results The odds of PJI recurrence within 104 weeks of follow-up in the study group were five times lower than in the comparison group ( OR = 0.2), with recurrence rates of 10.5 % and 45.0 %, respectively ( p = 0.031). The study group demonstrated significantly higher implant survival compared with the comparison group: implant survival at 104 weeks reached 89 % and 55 %, respectively. The mean risk ratio for implant loss in the David Cox proportional hazards model was 0.17 (log-rank test, p = 0.012). The study group also showed a significantly higher proportion of recovered patients compared with the comparison group, with rates of 89.5 % and 55.0 %, respectively ( OR = 6.3; p = 0.031). Discussion The results obtained for the causative PJI agents are consistent with the data in the literature. Both groups were dominated by cefoxime-resistant forms of staphylococci as a marker antibiotic, which reflects the PJI patterns of development in arthroplasty. The use of antibacterial drugs in large doses for eradication of pathogenic bacteria in biofilms leads to the accumulation of mutations in the genomes of the causative PJI agents, which is the reason for the development of drug resistance and recurrence of infection. The use of alternative therapies for PJI, in particular phage therapy, may change the treatment strategy. Adjuvant phage therapy has potential in the PJI caused by antibiotic-resistant pathogens. Conclusion Adjuvant phage therapy combined with antibiotic therapy is an effective treatment modality for periprosthetic hip joint infection caused by multidrug-resistant pathogens and may significantly reduce the recurrence rate of periprosthetic infection and thereby improve clinical outcomes. Further large randomized studies are required to confirm our findings and to use this method.
- Open Access
- 11 June 2025
- Published by ECO-Vector LLC in Traumatology and Orthopedics of Russia
- Vol. 31 (2) , 18-32
Recurrent Cases of Periprosthetic Joint Infection Caused by Staphylococcus Aureus: Reinfection or Reactivation of a Pathogen?
Background. Staphylococcus aureus is one of the most common pathogens causing periprosthetic joint infection (PJI). Despite the high genetic diversity of S. aureus strains, determining phylogenetic relationships and, consequently, the source of infection is a challenging task that can only be addressed through detailed comparison of the genomes of the obtained isolates. The aim of the study was to assess the feasibility of differentiating the cases of nosocomial periprosthetic joint infections, using whole-genome sequencing to identify genetic and phenotypic differences between isolates with the prospect of the application of evidence-based treatment strategies. Methods. Genomes of 20 S. aureus isolates from 13 patients with PJI were sequenced. Standard microbiological tests and in silico analysis of genomes using ResFinder, KmerFinder, spaTyper, and SCCmecFinder programs were employed. Results. Phylogenetic analysis was performed using core genome reconstruction and identified potential cases of nosocomial infections, as well as cases of recurrent infections. The relatedness of isolates collected between 2012 and 2019 was demonstrated, along with the evolution of their genomes, including the acquisition and loss of antibiotic resistance genes. In one case of recurrent infection, the loss of several genes was observed over a remission period of approximately 5 years. Comparison of phenotypic testing results using the disk diffusion method and resistance predictions based on genome analysis revealed discrepancies for three isolates containing the aac(6’)-aph(2’’) gene, which were resistant to tobramycin and gentamicin but susceptible to amikacin. Based on the treatment outcomes of several recurrent PJI cases, it was hypothesized that radical treatment might be more effective in cases of infections caused by multidrug-resistant nosocomial strains. Conclusions. Whole-genome sequencing enables the identification of phylogenetically related isolates, with shared genetic and phenotypic properties confirming their relatedness. Against the backdrop of high-dose antibiotic therapy, S. aureus genomes accumulate changes that, through molecular genetic testing, may help to justify the choice of radical treatment strategy for periprosthetic joint infection, such as prosthesis removal.
- 11 June 2025
- Published by ECO-Vector LLC in Traumatology and Orthopedics of Russia
- Vol. 31 (2) , 18-32
Open AccessRecurrent Cases of Periprosthetic Joint Infection Caused by Staphylococcus Aureus: Reinfection or Reactivation of a Pathogen?
Background. Staphylococcus aureus is one of the most common pathogens causing periprosthetic joint infection (PJI). Despite the high genetic diversity of S. aureus strains, determining phylogenetic relationships and, consequently, the source of infection is a challenging task that can only be addressed through detailed comparison of the genomes of the obtained isolates. The aim of the study was to assess the feasibility of differentiating the cases of nosocomial periprosthetic joint infections, using whole-genome sequencing to identify genetic and phenotypic differences between isolates with the prospect of the application of evidence-based treatment strategies. Methods. Genomes of 20 S. aureus isolates from 13 patients with PJI were sequenced. Standard microbiological tests and in silico analysis of genomes using ResFinder, KmerFinder, spaTyper, and SCCmecFinder programs were employed. Results. Phylogenetic analysis was performed using core genome reconstruction and identified potential cases of nosocomial infections, as well as cases of recurrent infections. The relatedness of isolates collected between 2012 and 2019 was demonstrated, along with the evolution of their genomes, including the acquisition and loss of antibiotic resistance genes. In one case of recurrent infection, the loss of several genes was observed over a remission period of approximately 5 years. Comparison of phenotypic testing results using the disk diffusion method and resistance predictions based on genome analysis revealed discrepancies for three isolates containing the aac(6’)-aph(2’’) gene, which were resistant to tobramycin and gentamicin but susceptible to amikacin. Based on the treatment outcomes of several recurrent PJI cases, it was hypothesized that radical treatment might be more effective in cases of infections caused by multidrug-resistant nosocomial strains. Conclusions. Whole-genome sequencing enables the identification of phylogenetically related isolates, with shared genetic and phenotypic properties confirming their relatedness. Against the backdrop of high-dose antibiotic therapy, S. aureus genomes accumulate changes that, through molecular genetic testing, may help to justify the choice of radical treatment strategy for periprosthetic joint infection, such as prosthesis removal.
- Open Access
- 17 October 2021
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 6 (4) , 50-63
Short-term results of treatment of staphylococcal periprosthetic hip joint infection with combined antibiotics and bacteriophages treatment
Infectious complications after primary implantation of the hip joint are 0.5–3 %, and in the case of re-endoprosthetics, the risk of periprosthetic infection can reach 30 %. Also, we should not forget about the high percentage (16–20 %) of recurrence of periprosthetic infection of the hip joint, which leads to an unsatisfactory result of treatment up to amputation of a limb or even death of the patient. The reasons for the recurrence of the infectious process can be antibiotic resistance and antibiotic tolerance of microorganisms, as well as the ability of microorganisms to form biofilms on implants. In this regard, there is a constant need to search for alternative means of antimicrobial therapy, as well as to select the optimal ways of their delivery and deposition, which is of practical importance when performing surgical interventions in traumatology and orthopedics to protect the implantable structure from possible infection of the surgical site. One of the methods currently available to combat bacterial infections acquired antibiotic resistance and antibiotic tolerance is the use of natural viruses that infect bacterial bacteriophages. The above suggests a more effective suppression of periprosthetic infection, including persisters that deviate from antibiotics. It is, as a rule, associated with biofilms if used in conjunction with antibiotics and phages, when the use of bacteriophages predetermines the effectiveness of treatment. With the use of sensitive bacteriophages in the treatment of periprosthetic infections, a significant (p = 0.030) reduction in the rate of recurrence of infection (from 31 to 4.5 %) was observed. The use of lytic bacteriophages in traumatology and orthopedics is of great interest for phagotherapy of infections caused by antibiotic-resistant and biofilm-forming strains of bacteria. A clinical study using a single-stage surgical revision with simultaneous application of antibiotics and phages in the treatment of deep periprosthesis infection of the hip joint endoprosthesis, followed by 12 months follow-up for periprosthetic infection recurrence, demonstrated the effectiveness of the use of combined antibiotic and bacteriophages treatment.
- 17 October 2021
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 6 (4) , 50-63
Open AccessShort-term results of treatment of staphylococcal periprosthetic hip joint infection with combined antibiotics and bacteriophages treatment
Infectious complications after primary implantation of the hip joint are 0.5–3 %, and in the case of re-endoprosthetics, the risk of periprosthetic infection can reach 30 %. Also, we should not forget about the high percentage (16–20 %) of recurrence of periprosthetic infection of the hip joint, which leads to an unsatisfactory result of treatment up to amputation of a limb or even death of the patient. The reasons for the recurrence of the infectious process can be antibiotic resistance and antibiotic tolerance of microorganisms, as well as the ability of microorganisms to form biofilms on implants. In this regard, there is a constant need to search for alternative means of antimicrobial therapy, as well as to select the optimal ways of their delivery and deposition, which is of practical importance when performing surgical interventions in traumatology and orthopedics to protect the implantable structure from possible infection of the surgical site. One of the methods currently available to combat bacterial infections acquired antibiotic resistance and antibiotic tolerance is the use of natural viruses that infect bacterial bacteriophages. The above suggests a more effective suppression of periprosthetic infection, including persisters that deviate from antibiotics. It is, as a rule, associated with biofilms if used in conjunction with antibiotics and phages, when the use of bacteriophages predetermines the effectiveness of treatment. With the use of sensitive bacteriophages in the treatment of periprosthetic infections, a significant (p = 0.030) reduction in the rate of recurrence of infection (from 31 to 4.5 %) was observed. The use of lytic bacteriophages in traumatology and orthopedics is of great interest for phagotherapy of infections caused by antibiotic-resistant and biofilm-forming strains of bacteria. A clinical study using a single-stage surgical revision with simultaneous application of antibiotics and phages in the treatment of deep periprosthesis infection of the hip joint endoprosthesis, followed by 12 months follow-up for periprosthetic infection recurrence, demonstrated the effectiveness of the use of combined antibiotic and bacteriophages treatment.
- Open Access
- 2 December 2020
- Published by ECO-Vector LLC in Traumatology and Orthopedics of Russia
- Vol. 26 (4) , 121-129-129
Translocation of Clostridial Infection as a Complication of Hip Arthroplasty in the Early Postoperative Period: Case Report
Background. Periprosthetic joint infection in the early postoperative period is a severe infectious complication. Its development, as a rule, is associated with the exogenous surgical wound infection, with the iatrogenic factor at the forefront. Clinical case description. A 73-years-old female with left-sided idiopathic 3rd stage hip osteoarthritis and concomitant pathology with a high degree of comorbidity underwent left hip arthroplasty with a cement-fixed “Endoservice” endoprosthesis. In the early postoperative period (4th to 6th days), against the background of chronic calculous cholecystitis exacerbation and gastrointestinal dysfunction, clostridial septicemia developed as a result of bacterial translocation. The timely diagnosis of the endogenous nature of this infection and the targeted antibiotic therapy prevented the surgical wound and endoprosthesis infection. The Harris score for the function of the left hip at discharge was 78 points. Conclusion. The presented clinical case demonstrates the importance of careful preoperative planning, especially in the patient with identifying somatic pathology of infectious nature, the need to detail the organ-specific microbiota as a mandatory procedure, as well as the prevention of periprosthetic joint infection during orthopedic operations, taking into account the data obtained.
- 2 December 2020
- Published by ECO-Vector LLC in Traumatology and Orthopedics of Russia
- Vol. 26 (4) , 121-129-129
Open AccessTranslocation of Clostridial Infection as a Complication of Hip Arthroplasty in the Early Postoperative Period: Case Report
Background. Periprosthetic joint infection in the early postoperative period is a severe infectious complication. Its development, as a rule, is associated with the exogenous surgical wound infection, with the iatrogenic factor at the forefront. Clinical case description. A 73-years-old female with left-sided idiopathic 3rd stage hip osteoarthritis and concomitant pathology with a high degree of comorbidity underwent left hip arthroplasty with a cement-fixed “Endoservice” endoprosthesis. In the early postoperative period (4th to 6th days), against the background of chronic calculous cholecystitis exacerbation and gastrointestinal dysfunction, clostridial septicemia developed as a result of bacterial translocation. The timely diagnosis of the endogenous nature of this infection and the targeted antibiotic therapy prevented the surgical wound and endoprosthesis infection. The Harris score for the function of the left hip at discharge was 78 points. Conclusion. The presented clinical case demonstrates the importance of careful preoperative planning, especially in the patient with identifying somatic pathology of infectious nature, the need to detail the organ-specific microbiota as a mandatory procedure, as well as the prevention of periprosthetic joint infection during orthopedic operations, taking into account the data obtained.